Novel 1,5-naphthyridine PI3K delta inhibitors, an evaluation of WO2011075628

[摘要]：A small series of aryl(1-arylamino) ethyl, 1,5-naphthyridine derivatives that selectively inhibit PI3K delta was prepared. The compounds are claimed to be useful in the treatment of cancer, inflammatory and autoimmune diseases. The compounds represent further variations around a structural motif explored in a number of previous applications by the applicant.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内